📈 Markets & Finance risk-off · 6–18 months
A what‑if from the future

What if Mega-merger attempt collides with FTC and freezes deal sentiment?

A blocked or litigated pharma mega-deal revives antitrust fears, chilling the M&A bid that underpins biotech valuations and triggering a small-cap biotech pullback.

22%
our model probability
over 6–18 months
prediction markets — wisdom of the crowd
loading live odds…
Empirically anchored 22% · 90% range 1–44% · 40 analogues · measured class health 24% in 18 mo · 3% held back for the unknown
how we built this number — every step
Measured class rate — health ≈0.1843/yr → 24% in 18 mo24%
Analyst prior · editorial share 100% of the class30%
Pooled · weight 87%23%
Crowd — no liquid market
Reserve 3% · no extremizing (×1.0)23%
Published22%

The class rate is measured from our dated, sourced event library (decade-normalized Poisson — the full table is public at base_rates.json). The variant’s share within its class is the analyst’s editorial call, published so you can audit it. A wider range means thinner precedent. Full recipe: methodology · scored at Reality Check.

The butterfly cascade

How this trigger trickles across markets, left → right — the root shock, its first‑order moves, then the ripple effects. Drag any node; tap a market for its real price history.

Resolution timeline — how this probability is moving

Our model's odds (gold) over time vs the crowd's (Polymarket, blue), from the past toward the 6–18 months horizon. Each dot is a real macro event that nudged the probability — green pushed it up, red pushed it down. Tap a dot for the source. The gold path is an illustrative reconstruction anchored to today's estimate — real dated events, not a live re-estimate history.

loading the timeline…

What it would mean

If this plays out, it is a risk-off shock. A blocked or litigated pharma mega-deal revives antitrust fears, chilling the M&A bid that underpins biotech valuations and triggering a small-cap biotech pullback. The trigger decomposes into signed root‑shocks — Biotech breakthrough ▼ · Credit spreads ▲ · Risk appetite ▼ — which propagate through our causal graph to the markets below.

If it happens — the markets it would move

Biggest moves first. Projected moves are cascade-model priors; hist A–B% = what comparable past events actually did (measured abnormal returns), and model prior · unmeasured marks markets with no analogue backing yet. Tap any market for its price history.

MarketClassProjected move
1Solana SOLon Hyperliquid 📈 chartCrypto▼ -0.6%
hist -11.77–+2.86%
2Hyperliquid (HYPE) HYPEon HyperliquidCrypto▼ -0.5%
model prior · unmeasured
3Ether ETHon Hyperliquid 📈 chartCrypto▼ -0.4%
hist -3.8–+1.97%
4Nasdaq 100 NDXon Hyperliquid 📈 chartIndex▼ -0.4%
hist -0.23–-0.09%
5MicroStrategy MSTRon Hyperliquid 📈 chartEquity▼ -0.4%
hist -2.04–+3.45%
6Bitcoin BTCon Hyperliquid 📈 chartCrypto▼ -0.3%
hist -1.91–+3.16%
7Volatility (VIX) VIXon Hyperliquid 📈 chartVol▲ +0.3%
hist -1.14–+2.62%
8S&P 500 SPXon Hyperliquid 📈 chartIndex▼ -0.2%
hist -0.52–+0.11%
9High-yield credit HYG 📈 chartRate▼ -0.2%
hist -0.37–+0.03%
10Tech sector XLK 📈 chartEquity▼ -0.2%
hist -0.44–+0.67%
11Coinbase COINon Hyperliquid 📈 chartEquity▼ -0.2%
hist -1.06–+0.58%
12Semiconductors SMHon Hyperliquid 📈 chartEquity▼ -0.2%
hist -0.56–+1.71%

Probable recommendation

If the scenario above plays out, the probable cross‑asset positioning → a scenario‑conditional read, not personalized investment advice
Cash / hedgeRaise cash and hold the long hedges above; this scenario is net risk-off.
For a common-man portfolio: A typical stock-heavy portfolio is at risk. Consider trimming equities, raising cash, and a small cash hedge.
Also moves (not yet on Hyperliquid): High-yield credit -0.2% · Tech sector -0.2%

Historical precedent — what analogous events actually did

Across 40 analogous events (overlap‑weighted), as abnormal returns — market beta stripped, so it's the event's own effect, not the market backdrop. Shown at 20 days (persistent) and 5 days (immediate); ↺ fades = the two horizons disagree. Confidence = consistency × sample × significance.

Wegovy 2021-06 First mRNA COVID-19 vaccine authorized 2020-12 Casgevy — first CRISPR gene-editing medicine approved 2023-12 mRNA pioneers win the Nobel 2023-10 First genetically-modified pig-to-human heart transplant 2022-01 AlphaFold cracks the protein-folding problem 2020-11 He Jiankui announces CRISPR-edited babies 2018-11 Human Genome Project completed 2003-04 Nikkei 225 record single-day rebound 2024-08 Neuralink implants its first human brain-computer interface 2024-01 LK-99 room-temperature superconductor claim 2023-07 First Republic Bank seized and sold to JPMorgan 2023-05 OpenAI releases GPT-4 2023-03 Regional-bank panic deepens after Signature seizure 2023-03 NIF achieves fusion ignition 2022-12 Kaisa Group offshore default 2021-12 AlphaGo defeats Lee Sedol 2016-03 SpaceX lands an orbital rocket booster 2015-12 HYG record outflows in 2014 high-yield rout 2014-10 Mt. Gox collapse 2014-02 Mt. Gox halts withdrawals 2014-02 Cyprus deposit bail-in 2013-03 Spain requests EUR100bn bank bailout 2012-06 Bankia nationalised in Spain's banking crisis 2012-05 Portugal requests EU-IMF bailout 2011-04 EU/IMF EUR750bn rescue weekend 2010-05 Greece first EU/IMF bailout 2010-05 Greece requests EU/IMF bailout 2010-04 Anglo Irish Bank nationalisation 2009-01 Fannie Mae and Freddie Mac conservatorship 2008-09 IndyMac Bank seized by the Office of Thrift Supervision 2008-07 2008 global rice crisis: Thai benchmark tops $1,000/ton 2008-04 Northern Rock bank run 2007-09 American Home Mortgage bankruptcy 2007-08 Bear Stearns freezes redemptions on subprime hedge funds 2007-06 New Century Financial bankruptcy 2007-04 Turkey lets the lira float 2001-02 Mexico $50bn international rescue package 1995-01 Soviet August coup attempt against Gorbachev 1991-08 Hong Kong Stock Exchange four-day closure after Black Monday 1987-10
AssetHistory saysAbnormal (20d · 5d)HitnConfidencevs cascade
SOL SOLSHORT-10.2% · 5d -9.8%83%14 0.49✓ matches cascade
SMH SMHLONG+1.6% · 5d -0.1% ↺ fades64%37 0.23⚠ differs
High-yield credit HYGSHORT-0.2% · 5d -0.1%62%34 0.19✓ matches cascade
Gold XAULONG+0.5% · 5d +0.1%58%37 0.15·
COIN COINSHORT-1.0% · 5d +0.5% ↺ fades59%12 0.12✓ matches cascade
ETH ETHSHORT-3.6% · 5d -6.8%56%15 0.10✓ matches cascade
NDX NDXLONG+0.0% · 5d -1.1% ↺ fades56%40 0.09⚠ differs
Bitcoin BTCLONG+3.3% · 5d -4.4% ↺ fades53%18 0.06⚠ differs
XLK XLKLONG+0.8% · 5d -0.3% ↺ fades54%37 0.06⚠ differs
10y yield DGS10SHORT-5bp · 5d -2bp52%40 0.04·
MSTR MSTRLONG+3.7% · 5d -2.0% ↺ fades44%37 0.00⚠ differs
Volatility VIXLONG+2.4% · 5d -2.0% ↺ fades48%39 0.00✓ matches cascade
SPX SPXSHORT-0.4% · 5d +0.8% ↺ fades41%40 0.00✓ matches cascade
US dollar DXYLONG+0.1% · 5d -0.1% ↺ fades46%40 0.00·

Methodology. Probability and impact are anchored to history and scored against what actually happens — wins and losses, in public, at Reality Check. Crowd odds live from Polymarket & Kalshi. By Vikas Singh, Quantitative Strategist. Updated 2026-07-03.